查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1559734

左心室輔助裝置 (LVAD) 的全球市場

Left Ventricular Assist Device (LVAD)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球左心室輔助裝置 (LVAD) 市場將達到 26 億美元

左心室輔助裝置 (LVAD) 的全球市場預計到 2023 年將達到 15 億美元，預計在 2023 年至 2030 年分析期間將以 7.6% 的複合年成長率成長，並在 2030 年達到 26 億美元。醫院最終用途是本報告分析的細分市場之一，預計複合年成長率為 6.1%，到分析期結束時將達到 13 億美元。分析期間，臨床最終用途細分市場的複合年成長率預計為 9.9%。

美國市場預估為4.234億美元，中國預期複合年成長率為7.2%

預計 2023 年美國左心室輔助裝置 (LVAD) 市場規模將達到 4.234 億美元。中國作為世界第二大經濟體，預計到 2030 年市場規模將達到 4.027 億美元，2023-2030 年分析期間複合年成長率為 7.2%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 6.8% 和 6.4%。在歐洲，德國的複合年成長率預計約為 6.2%。

全球左心室輔助裝置 (LVAD) 市場 - 主要趨勢和促進因素總結

什麼是左心室輔助循環裝置（LVAD）？

左心室輔助裝置 (LVAD) 是一種機械泵，用於支持心臟虛弱或嚴重心臟衰竭患者的心臟功能和血流。 LVAD 通常在治療不再有效時使用，並在患者等待捐贈心臟時提供關鍵支持，作為心臟移植的橋樑。另外，對於不適合移植的患者，LVAD 可以作為目標治療，並提供長期支持作為護理標準。這些裝置透過手術植入，透過從左心室抽取血液並將其輸送到主動脈來工作，有效地補充或取代心臟主室的泵血功能。 LVAD 技術的進步顯著提高了患者的生活品質和存活率，使該設備成為治療晚期心臟衰竭的重要選擇。

技術創新如何形塑 LVAD 市場？

LVAD 設計和功能的技術進步極大地提高了其有效性和患者適用性。現代 LVAD 更加緊湊、侵入性更小，並採用連續流動技術，可降低血栓和感染疾病等設備相關併發症的風險。磁力軸承和動態軸承等創新技術可最大限度地減少設備的物理磨損，延長其使用壽命和可靠性。此外，與以前的限制性更強的型號相比，電池壽命和便攜性的提高使患者擁有更多的自由度和移動性。這些技術進步不僅增加了 LVAD 的盛行率，而且擴大了 LVAD 植入的潛在候選人群，包括老年患者和健康狀況複雜的患者。

LVAD市場存在哪些挑戰與機會？

儘管取得了重大進展，LVAD 市場仍面臨影響患者治療結果和廣泛採用的挑戰。移植手術的侵入性以及出血、中風和感染等嚴重併發症的風險是阻礙潛在候選人的重要擔憂。此外，新興國家的 LVAD 成本（包括設備本身、手術和術後護理）仍然讓許多患者和醫療保健系統望而卻步，尤其是在低度開發國家。然而，這些挑戰也為市場創新和成長提供了機會。不斷需要研究和開發來創造能夠解決這些問題的侵入性較小、可靠且具有成本效益的設備。顯著改善患者治療效果的潛力繼續推動人們對開發能夠克服當前局限性的下一代 LVAD 的投資和興趣。

LVAD 市場成長由多種因素推動

LVAD 市場的成長是由反映人口趨勢、技術進步和醫療保健發展的多種因素所推動的。全球心臟衰竭盛行率不斷上升，加上世界人口老化，導致對 LVAD 等先進治療方案的需求增加。提高使用這些設備的患者的安全性和生活品質的技術創新是使其對患者和臨床醫生更具吸引力的關鍵促進因素。此外，患者選擇和術前護理的改進正在最佳化 LVAD 患者的治療效果，並提高該治療方法的成功率和可靠性。最後，一些國家醫療保健支出的增加和先進醫療保險覆蓋範圍的擴大，使得 LVAD 可供更廣泛的患者使用，進一步刺激了市場成長。這些因素共同促進了 LVAD 市場的動態擴張，使 LVAD 成為現代心臟治療的重要組成部分。

調查企業舉例（共13家）

  • Evaheart, Inc.
  • Peripal AG

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP13131

Global Left Ventricular Assist Device (LVAD) Market to Reach US$2.6 Billion by 2030

The global market for Left Ventricular Assist Device (LVAD) estimated at US$1.5 Billion in the year 2023, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Clinics End-Use segment is estimated at 9.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$423.4 Million While China is Forecast to Grow at 7.2% CAGR

The Left Ventricular Assist Device (LVAD) market in the U.S. is estimated at US$423.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$402.7 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Left Ventricular Assist Device (LVAD) Market - Key Trends & Drivers Summarized

What Are Left Ventricular Assist Devices (LVADs) and How Do They Support Heart Health?

Left Ventricular Assist Devices (LVADs) are mechanical pumps used to support heart function and blood flow in individuals with weakened hearts or severe heart failure. Typically employed when medical treatments are no longer effective, LVADs can be used as a bridge to heart transplantation, providing vital support while a patient awaits a donor heart. Alternatively, for patients who are not candidates for transplantation, LVADs can be used as a destination therapy, offering long-term support as a standard of care. These devices are surgically implanted and work by taking blood from the left ventricle and pumping it to the aorta, effectively aiding or taking over the pumping function of the heart's main chamber. Advances in LVAD technology have significantly improved the quality of life and survival rates for patients, making these devices a crucial option in managing advanced heart failure.

How Is Technological Innovation Shaping the LVAD Market?

Technological advancements in the design and functionality of LVADs have dramatically enhanced their effectiveness and patient compatibility. Modern LVADs are more compact, less invasive, and equipped with continuous flow technology that reduces the risk of device-related complications, such as blood clots and infections. Innovations such as magnetic and hydrodynamic bearings have minimized the physical wear on the device, extending their usable life and reliability. Additionally, improvements in battery life and portability allow patients more freedom and mobility than earlier models, which were more restrictive. These technological improvements have not only increased the adoption rates of LVADs but have also broadened the potential candidate pool for LVAD implantation, including older patients and those with complex health profiles.

What Challenges and Opportunities Exist Within the LVAD Market?

Despite significant advancements, the LVAD market faces challenges that affect both patient outcomes and broader adoption. The invasive nature of the implantation procedure and the risk of serious complications such as bleeding, stroke, and infection are considerable concerns that can deter potential candidates. Moreover, the cost of LVADs, including the device itself, surgery, and post-operative care, remains prohibitively high for many patients and healthcare systems, particularly in less developed countries. However, these challenges also present opportunities for innovation and growth within the market. There is a constant demand for research and development to produce less invasive, more reliable, and cost-effective devices that could address these issues. The potential for significant improvements in patient outcomes continues to drive investment and interest in developing next-generation LVADs that could overcome current limitations.

Growth in the LVAD Market Is Driven by Several Factors

The growth in the LVAD market is driven by several factors, reflecting a combination of demographic trends, technological advancements, and evolving healthcare practices. Increasing prevalence of heart failure worldwide, coupled with an aging global population, has resulted in a higher demand for advanced treatment options like LVADs. Technological innovations that enhance the safety and quality of life for patients using these devices are key growth drivers, making the devices more appealing to both patients and clinicians. Additionally, improvements in patient selection and pre-operative care have optimized outcomes for LVAD recipients, increasing the success rates and confidence in this treatment approach. Finally, growing healthcare expenditures and expanding insurance coverage for advanced medical treatments in several countries are making LVADs accessible to a broader range of patients, further stimulating market growth. These factors collectively contribute to the dynamic expansion of the LVAD market, making it a vital component of modern cardiac care.

Select Competitors (Total 13 Featured) -

  • Evaheart, Inc.
  • Peripal AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Left Ventricular Assist Device (LVAD) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Left Ventricular Assist Device (LVAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Left Ventricular Assist Device (LVAD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Left Ventricular Assist Device (LVAD) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Left Ventricular Assist Device (LVAD) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Rest of Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Asia-Pacific 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of World 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION